(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | -21.91%413.71M | 18.42%928.91M | 46.71%529.78M | 32.50%784.44M | --361.1M | 18.06%592.01M | --501.47M |
Operating income | -21.91%413.71M | 18.42%928.91M | 46.71%529.78M | 32.50%784.44M | 361.1M | 18.06%592.01M | 501.47M |
Cost of sales | 25.53%-254.05M | -8.92%-596.32M | -41.17%-341.15M | -31.35%-547.49M | ---241.66M | -20.97%-416.83M | ---344.58M |
Operating expenses | 25.53%-254.05M | -8.92%-596.32M | -41.17%-341.15M | -31.35%-547.49M | -241.66M | -20.97%-416.83M | -344.58M |
Gross profit | -15.36%159.66M | 40.37%332.6M | 57.93%188.63M | 35.25%236.95M | 119.44M | 11.66%175.19M | 156.9M |
Selling expenses | 4.46%-32.96M | -34.56%-65.56M | -63.19%-34.5M | 35.85%-48.73M | ---21.14M | -136.87%-75.95M | ---32.06M |
Administrative expenses | -36.98%-111.09M | -25.54%-181.68M | -29.28%-81.1M | 62.87%-144.71M | ---62.74M | -230.98%-389.75M | ---117.76M |
Research and development expenses | 2.82%-5.72M | -11.85%-12.84M | -12.68%-5.88M | 3.25%-11.48M | ---5.22M | -40.44%-11.87M | ---8.45M |
Impairment and provision | 67.28%-1.36M | -379.78%-16.87M | -202.76%-4.17M | 67.69%-3.52M | ---1.38M | -217.84%-10.89M | ---3.43M |
-Other impairment is provision | 67.28%-1.36M | -379.78%-16.87M | -202.76%-4.17M | 67.69%-3.52M | ---1.38M | -217.84%-10.89M | ---3.43M |
Special items of operating profit | -32.17%6.85M | 59.08%16.6M | 233.99%10.1M | -32.27%10.44M | --3.02M | 21.07%15.41M | --12.73M |
Operating profit | -78.96%15.38M | 85.48%72.24M | 128.42%73.08M | 113.08%38.95M | 31.99M | -3,858.47%-297.86M | 7.93M |
Financing income | -41.98%1.14M | -31.01%3.26M | -19.16%1.97M | 355.25%4.73M | --2.44M | 142.19%1.04M | --429K |
Financing cost | 12.50%-11.05M | 33.60%-24.79M | 17.44%-12.63M | 39.94%-37.34M | ---15.3M | 48.61%-62.17M | ---120.97M |
Special items of earning before tax | 84.91%-1.1M | -35.68%-7.34M | -172.54%-7.27M | -47.30%-5.41M | ---2.67M | -294.39%-3.67M | --1.89M |
Earning before tax | -92.07%4.37M | 4,539.68%43.38M | 234.93%55.15M | 100.26%935K | 16.47M | -227.53%-362.66M | -110.73M |
Tax | 56.56%-3.41M | 57.44%-6.81M | 11.35%-7.86M | 17.13%-15.99M | ---8.86M | -103.82%-19.3M | ---9.47M |
After-tax profit from continuing operations | -97.97%962K | 342.89%36.57M | 521.94%47.29M | 96.06%-15.06M | 7.6M | -217.78%-381.96M | -120.2M |
Earning after tax | -97.97%962K | 342.89%36.57M | 521.94%47.29M | 96.06%-15.06M | 7.6M | -217.78%-381.96M | -120.2M |
Minority profit | -166.64%-2.87M | 49.16%-7.84M | 185.64%4.31M | 27.35%-15.42M | ---5.04M | -13.90%-21.23M | ---18.64M |
Profit attributable to shareholders | -91.07%3.84M | 12,101.92%44.42M | 240.02%42.98M | 100.10%364K | 12.64M | -255.20%-360.73M | -101.56M |
Basic earnings per share | -91.34%0.011 | 13,000.00%0.131 | 243.24%0.127 | 100.09%0.001 | 0.037 | -223.76%-1.172 | -0.362 |
Diluted earnings per share | -91.34%0.011 | 13,000.00%0.131 | 243.24%0.127 | 100.09%0.001 | 0.037 | -223.76%-1.172 | -0.362 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data